Site icon YCNews

Australian Drug Administration: Australia’s second blood clotting case may be related to vaccination against AstraZeneca

Australian Drug Administration: Australia's second blood clotting case may be related to vaccination against AstraZeneca

△Picture from Australian media

April 13th, local time, the Australian Drug Administration said that the second blood clotting case in Western Australia may be related to the injection of AstraZeneca coronavirus vaccine. The study found that the symptoms of this case are similar to those previously found in many European countries, including the low platelet number of patients.

The case was a woman in her 40s who had been vaccinated against AstraZeneca and is currently in hospital and is in stable condition, the Australian Drug Administration said in a statement.

After confirming the association between blood clotting and AstraZeneca vaccine, Australia has changed its priority option for vaccination against the novel coronavirus, from AstraZeneca to Pfizer vaccine in the United States, and suspended the vaccination of AstraZeneca vaccine for people under 50.

The Australian government has been forced to abandon its national vaccination progress target due to the Australian government’s suspension of British vaccine use and slow delivery of vaccines in the United States.

Exit mobile version